Page 5 - Sam Gandy News Today

Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.

Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.

The drug, lecanemab also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.

The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.

/PRNewswire/ -- A change in the DNA code (mutation) of a gene that plays a key role in the brains immune defenses may prevent related cells from clearing away...

Lecanemab met primary and secondary endpoints, but was associated with adverse events

WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- The experimental Alzheimer’s drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain.

Medically reviewed by Dr. Ari Magill First described by Alois Alzheimer in 1906, Alzheimer's disease (AD) is a ...

Gum disease has far-reaching effects and may increase your odds of developing dementia, a new study suggests. In ...

THURSDAY, Sept. 22, 2022 (HealthDay News) -- No one likes nightmares, but having persistently bad dreams may also signal impending dementia, new British research suggests.